Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues

J Med Chem. 2007 Nov 29;50(24):6212-25. doi: 10.1021/jm070839q. Epub 2007 Oct 27.

Abstract

Di-2-pyridylketone isonicotinoyl hydrazone Fe chelators utilize the N,N,O-donor set and have moderate anti-proliferative effects. Their closely related N,N,S-thiosemicarbazone analogues, namely, the di-2-pyridylketone thiosemicarbazones, exhibit markedly increased anti-proliferative and redox activity, and this was thought to be due to the inclusion of a sulfur donor atom (Richardson, D. R. et al. J. Med. Chem. 2006, 49, 6510-6521). To further examine the effect of donor atom identity on anti-proliferative activity, we synthesized thiohydrazone analogues of extensively examined aroylhydrazone chelators. The O,N,S-thiohydrazones exhibited decreased anti-proliferative effects compared to their parent aroylhydrazones and reduced redox activity. In contrast, the N,N,S-thiohydrazones showed vastly increased anti-proliferative activity compared to their hydrazone analogues, being comparable to potent thiosemicarbazones. Additionally, N,N,S-thiohydrazone complexes had reversible FeIII/II couples and exhibited increased redox activity. These observations demonstrate that the N,N,S-donor set is critical for potent anti-proliferative efficacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Ascorbic Acid / metabolism
  • Benzoates / metabolism
  • Cell Line
  • Cell Line, Tumor
  • Crystallography, X-Ray
  • Drug Design
  • Drug Screening Assays, Antitumor
  • Electrochemistry
  • Ferrous Compounds / chemical synthesis*
  • Ferrous Compounds / chemistry
  • Ferrous Compounds / pharmacology
  • Humans
  • Hydrazones / chemical synthesis*
  • Hydrazones / chemistry
  • Hydrazones / pharmacology
  • Hydroxylation
  • Iron / metabolism
  • Iron Chelating Agents / chemical synthesis*
  • Iron Chelating Agents / chemistry
  • Iron Chelating Agents / pharmacology
  • Ligands
  • Molecular Structure
  • Oxidation-Reduction
  • Structure-Activity Relationship
  • Thiones / chemical synthesis*
  • Thiones / chemistry
  • Thiones / pharmacology
  • Transferrin / metabolism

Substances

  • Antineoplastic Agents
  • Benzoates
  • Ferrous Compounds
  • Hydrazones
  • Iron Chelating Agents
  • Ligands
  • Thiones
  • Transferrin
  • Iron
  • Ascorbic Acid